ClinicalTrials.gov
ClinicalTrials.gov Menu

Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01963663
Recruitment Status : Completed
First Posted : October 16, 2013
Last Update Posted : October 16, 2013
Sponsor:
Information provided by (Responsible Party):
Alireza Esteghamati, Tehran University of Medical Sciences